Letter by Guaricci et al Regarding Article, “Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with great interest the article written by Jablonowski et al1 aiming to investigate the key role that late gadolinium enhancement (LGE) plays in risk stratification of patients with ischemic and nonischemic cardiomyopathy. During the last decade, the need for added prognostic factors of arrhythmic risk in patients affected by dilated cardiomyopathy has been growing because of suboptimal success of the current indications for primary-prevention implantable cardioverter-defibrillator therapy. Recently, multiparametric cardiac magnetic resonance has been shown to predict the occurrence of arrhythmic major adverse cardiac events.2 The article of Jablonowski et al focused on a refined assessment …